Key Considerations for Healthcare Companies Listing on a US Exchange

Healthcare companies considering listing on a US exchange have several important decisions and steps ahead of them.

In the latest episode of our capital markets podcast series, DNB//Back Bay is privileged to sit down with the co-head of the global life science practice at Cooley to share best practices on the critical mechanics of a US listing, including practical steps and for preparation, how to build an IPO-ready team, preparing and submitting key documents, and the most common mistakes companies make during the listing process.

Guests: 

• Vasilios Kofitsas, Managing Director, Investment Banking, Back Bay Life Science Advisors 

• Kristoffer Braaten, Director, Head of ECM US, DNB Markets Inc.

• Marc Recht, Partner, Cooley LLP

About our IPO experts:

DNB//Back Bay is a committed partner throughout the healthcare development journey, addressing positioning, partnering, financing, M&A strategies, and listing support and execution on US and Nordic exchanges. Our team of more than 100 healthcare strategy and financial specialists spans the globe.

Learn more about the DNB//Back Bay Partnership and read our disclaimers.

Cooley is among the top law firms for healthcare, tech, and life science IPOs on both the issuer and underwriter sides. Its 1,300 lawyers are spread across 19 offices worldwide. Learn more.